Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Sell
19,859
-840
-4% -$181K 0.46% 39
2026
Q1
$4.5M Sell
20,699
-186
-0.9% -$41.3K 0.46% 40
2025
Q4
$4.77M Sell
20,885
-1,422
-6% -$324K 0.5% 35
2025
Q3
$5.17M Buy
22,307
+1,581
+8% +$322K 0.56% 31
2025
Q2
$3.85M Buy
20,726
+463
+2% +$86K 0.52% 34
2025
Q1
$4.25M Sell
20,263
-1,688
-8% -$328K 0.62% 32
2024
Q4
$3.9M Buy
21,951
+12
+0.1% +$2.21K 0.6% 36
2024
Q3
$4.33M Sell
21,939
-4,660
-18% -$870K 0.64% 33
2024
Q2
$4.56M Buy
26,599
+320
+1% +$53K 0.68% 30
2024
Q1
$4.79M Buy
26,279
+495
+2% +$85.3K 0.69% 30
2023
Q4
$4M Buy
25,784
+4,495
+21% +$655K 0.58% 40
2023
Q3
$3.17M Buy
21,289
+402
+2% +$59K 0.54% 43
2023
Q2
$2.81M Buy
20,887
+8,120
+64% +$1.19M 0.48% 50
2023
Q1
$1.88M Sell
12,767
-723
-5% -$111K 0.39% 61
2022
Q4
$2.01M Buy
13,490
+108
+0.8% +$16.6K 0.46% 52
2022
Q3
$1.8M Buy
13,382
+124
+0.9% +$17.8K 0.48% 46
2022
Q2
$2.03M Sell
13,258
-260
-2% -$39.7K 0.43% 51
2022
Q1
$2.19M Buy
13,518
+4,317
+47% +$627K 0.39% 49
2021
Q4
$1.25M Sell
9,201
-589
-6% -$69.6K 0.22% 103
2021
Q3
$1.06M Buy
9,790
+3,538
+57% +$404K 0.2% 116
2021
Q2
$711K Sell
6,252
-433
-6% -$48.8K 0.17% 129
2021
Q1
$745K Buy
6,685
+2,550
+62% +$273K 0.19% 117
2020
Q4
$443K Buy
4,135
+6
+0.1% +$577 0.2% 111
2020
Q3
$409K Sell
4,129
-1,922
-32% -$181K 0.2% 109
2020
Q2
$573K Buy
+6,051
New +$533K 0.22% 99

Other funds holding ABBV

Intrua Financial's ABBV Position: Q2 2026 in Review

Intrua Financial reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $181K and leaving 19,859 shares worth $5M. The position accounts for 0.46% of the portfolio, ranked #39.

Intrua Financial first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.17M in Q3 2025. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Intrua Financial held 19,859 shares of AbbVie worth $5M as of Q2 2026.
  • Intrua Financial sold 840 AbbVie shares in Q2 2026, an estimated $181K.
  • AbbVie made up 0.46% of Intrua Financial's portfolio in Q2 2026, its #39 holding.
  • Intrua Financial first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • Intrua Financial's AbbVie position peaked at $5.17M in Q3 2025.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.